These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Modulation of myocilin/TIGR expression in human trabecular meshwork. Tamm ER; Russell P; Epstein DL; Johnson DH; Piatigorsky J Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2577-82. PubMed ID: 10509652 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of myocilin in cultured human trabecular meshwork cells. Wentz-Hunter K; Shen X; Okazaki K; Tanihara H; Yue BY Exp Cell Res; 2004 Jul; 297(1):39-48. PubMed ID: 15194423 [TBL] [Abstract][Full Text] [Related]
8. Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Loewen N; Bahler C; Teo WL; Whitwam T; Peretz M; Xu R; Fautsch MP; Johnson DH; Poeschla EM Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3686-90. PubMed ID: 12454037 [TBL] [Abstract][Full Text] [Related]
10. Transduction of TAT fusion proteins into the human and bovine trabecular meshwork. Sakai H; Park BC; Shen X; Yue BY Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4427-34. PubMed ID: 17003436 [TBL] [Abstract][Full Text] [Related]
11. Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Vittitow JL; Garg R; Rowlette LL; Epstein DL; O'Brien ET; Borrás T Mol Vis; 2002 Mar; 8():32-44. PubMed ID: 11889464 [TBL] [Abstract][Full Text] [Related]
12. Expression of wild-type and truncated myocilins in trabecular meshwork cells: their subcellular localizations and cytotoxicities. Sohn S; Hur W; Joe MK; Kim JH; Lee ZW; Ha KS; Kee C Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3680-5. PubMed ID: 12454036 [TBL] [Abstract][Full Text] [Related]
13. Effects of time of storage, albumin, and osmolality changes on outflow facility (C) of bovine anterior segment in vitro. Gual A; Llobet A; Gilabert R; Borrás M; Palés J; Bergamini MV; Belmonte C Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2165-71. PubMed ID: 9331281 [TBL] [Abstract][Full Text] [Related]
14. Overexpression and properties of wild-type and Tyr437His mutated myocilin in the eyes of transgenic mice. Zillig M; Wurm A; Grehn FJ; Russell P; Tamm ER Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):223-34. PubMed ID: 15623777 [TBL] [Abstract][Full Text] [Related]
15. Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Borrás T; Rowlette LL; Erzurum SC; Epstein DL Gene Ther; 1999 Apr; 6(4):515-24. PubMed ID: 10476211 [TBL] [Abstract][Full Text] [Related]
16. The effect of cytochalasin D on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture. Johnson DH Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2790-9. PubMed ID: 9418732 [TBL] [Abstract][Full Text] [Related]
17. CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility. Zhong L; Geng L; Njie Y; Feng W; Song ZH Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1988-92. PubMed ID: 15914613 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo characterization of disulfide bond use in myocilin complex formation. Fautsch MP; Vrabel AM; Peterson SL; Johnson DH Mol Vis; 2004 Jun; 10():417-25. PubMed ID: 15235575 [TBL] [Abstract][Full Text] [Related]
19. Effects of elevated intraocular pressure on outflow facility and TIGR/MYOC expression in perfused human anterior segments. Borrás T; Rowlette LL; Tamm ER; Gottanka J; Epstein DL Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):33-40. PubMed ID: 11773009 [TBL] [Abstract][Full Text] [Related]
20. Perfusion with the olfactomedin domain of myocilin does not affect outflow facility. Goldwich A; Ethier CR; Chan DW; Tamm ER Invest Ophthalmol Vis Sci; 2003 May; 44(5):1953-61. PubMed ID: 12714629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]